Substance / Medication

Adenylic acid

Overview

Clinical overview including description, indications, and evidence base is pending physician authorship or FDA SPL integration. Graph-derived relationship data is available below.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Paroxysmal tachycardia

Ventricular pre-excitation with arrhythmia

Re-entrant atrioventricular node tachycardia

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:

Natural and artificial binders of polyriboadenylic acid and their effect on RNA structure.

Roviello Giovanni N, Musumeci Domenica, Roviello Valentina et al. · Beilstein J Nanotechnol · 2015

PMID: 26199837ReviewFull text (PMC)

The Inhibitory Effect of Adenylic Acid on the Bitterness of the Antibacterial Combination Drug Trimethoprim/Sulfamethoxazole.

Kawahara Jun, Yoshida Miyako, Kojima Honami et al. · Chem Pharm Bull (Tokyo) · 2023

PMID: 36858524Other

Adsorption of Polyadenylic acid on graphene oxide: experiments and computer modeling.

Karachevtsev Maksym V, Stepanian Stepan G, Valeev Vladimir A et al. · J Biomol Struct Dyn · 2022

PMID: 32897172Other

Influence of position of hydroxyl group of flavonoids on their binding with single stranded polyriboadenylic acid: A spectroscopic evaluation.

Chowdhury Susmita, Bhuiya Sutanwi, Haque Lucy et al. · Spectrochim Acta A Mol Biomol Spectrosc · 2021

PMID: 33038855Other

Interaction of proflavine with the RNA polynucleotide polyriboadenylic acid-polyribouridylic acid: photophysical and calorimetric studies.

Basu Anirban, Suresh Kumar Gopinatha · J Biomol Struct Dyn · 2020

PMID: 31057051Other

Interaction of cobalt(II) and copper(II) hydroxamates with polyriboadenylic acid: An insight into RNA based drug designing.

Thakur Yamini, Tripathi Mamta, Verma Bharati et al. · Nucleosides Nucleotides Nucleic Acids · 2019

PMID: 30732529Other

Self-structure assembly in single stranded polyriboadenylic acid by benzophenanthridine alkaloid: Spectroscopic and calorimetric exploration.

Haque Lucy, Bhuiya Sutanwi, Das Suman · Int J Biol Macromol · 2018

PMID: 28847605Other

Measurement of indicator genes using global complementary DNA (cDNA) amplification, by polyadenylic acid reverse transcriptase polymerase chain reaction (poly A RT-PCR): A feasibility study using paired samples from tissue and ductal juice in patients undergoing pancreatoduodenectomy.

Sanyal Sudip, Siriwardena Ajith K, Byers Richard · Pancreatology · 2018

PMID: 29574096Other

Transfection efficiency and internalization of the gene carrier prepared from a triple-helical β-glucan and polydeoxyadenylic acid in macrophage RAW264.7 cells.

Liu Qingye, Xu Hui, Cao Yan et al. · J Mater Chem B · 2015

PMID: 32262853Other

Nanoplatform Constructed from a β-Glucan and Polydeoxyadenylic Acid for Cancer Chemotherapy and Imaging.

Duan Bingchao, Zou Siwei, Sun Ying et al. · Biomacromolecules · 2019

PMID: 30799607Preclinical

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type: Substance / Medication
Fully Specified Name: Adenylic acid (substance)
SNOMED CT: 4864008
UMLS CUI: C0001465

Clinical Data

This intervention maps to 3 entities in the Healos knowledge graph.

Conditions

Biomarkers

Specialists

Symptoms

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.